Chu Yu-Waye
CIK 0001854586
Senior VP Clinical Development
Filings
13
Latest Mar 19, 2026
Issuers covered
2
Showing
13 of 13
Page 1
Track record
8 of 8 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 8 | 75% | +13.8% | +19.8% | +39.1% | -12.9% |
| 90 days | 7 | 86% | -27.3% | +24.6% | +25.2% | -307.3% |
| 180 days | 7 | 86% | +6.4% | +40.0% | +71.6% | -229.5% |
| 365 days | 7 | 86% | -46.0% | +16.8% | +88.0% | -628.5% |
Issuers
Companies where Chu Yu-Waye has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| CTMX | Cytomx Therapeutics, Inc. | 7 | Mar 19, 2026 |
| FATE | Fate Therapeutics Inc | 6 | Apr 19, 2023 |
All filings
13 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|